Twitter

Archive for April 3rd, 2012


Ovarian Hyperstimulation Syndrome and Cabergoline

Conditions :   Polycystic Ovarian Syndrome;   Ovarian Hyperstimulation Syndrome Intervention :   Drug: Cabergoline Sponsor :   Etlik Zubeyde Hanim Womens’ Health and Teaching Hospital Completed – verified March 2012

Read More...

Meal Timing on Glucose Metabolism and Hyperandrogenism in Lean Women With Polycystic Ovary Syndrome

Conditions :   Hyperandrogenism;   Insulin Resistance Intervention :   Other: Dietary intervention Sponsor :   Tel Aviv University Active, not recruiting – verified March 2012

Read More...

Young Adult Smoker’s Treatment Demand

Condition :   Smoking Cessation Intervention :   Behavioral: Online advertisement Sponsors :   University of Illinois;   National Cancer Institute (NCI);   University of Iowa;   American Legacy Foundation Recruiting – verified March 2012

Read More...

A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma

Condition :   CD20-positive B-cell Non-Hodgkin Lymphoma Interventions :   Drug: Part 1, Cohort 1;   Drug: Part 1, Cohort 2;   Drug: Part 1, Cohort 3;   Drug: Part 2, Cohort 1;   Drug: Part 2, Cohort 2 Sponsors :   Janssen Research & Development, LLC;   Pharmacyclics Not yet recruiting – verified March 2012

Read More...

Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma

Condition :   Hodgkin Lymphoma Interventions :   Drug: Etoposide;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Prednisone;   Drug: Procarbazine;   Drug: Dexamethasone;   Drug: Dacarbazine;   Drug: Brentuximab Vedotin Sponsor :   University of Cologne Not yet recruiting – verified March 2012

Read More...

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Condition :   Chronic Lymphocytic Leukemia Interventions :   Drug: GS-1101;   Drug: Rituximab;   Drug: Bendamustine;   Drug: Placebo Sponsor :   Gilead Sciences Not yet recruiting – verified March 2012

Read More...

Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility Study

Condition :   Breast Carcinoma Interventions :   Device: MRI;   Device: PET-CT scan;   Device: PEM scan with ClearPemSonic Sponsor :   Assistance Publique Hopitaux De Marseille Not yet recruiting – verified March 2012

Read More...

Effects of Reiki, Yoga, Meditation, on the Physical and Psychological Symptoms of Chemotherapy-Induced Peripheral Neuropathy

Condition :   Peripheral Neuropathy Interventions :   Behavioral: Yoga Intervention;   Behavioral: Meditation Intervention;   Behavioral: Reiki;   Other: Holistic Education Sponsor :   George Mason University Completed – verified April 2012

Read More...

A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma

Conditions :   Malignant;   Pleural;   Mesothelioma Interventions :   Biological: TroVax®;   Drug: Pemetrexed;   Drug: Cisplatin;   Dietary Supplement: Vitamin B12;   Dietary Supplement: Folic Acid;   Drug: Dexamethasone Sponsors :   Wales Cancer Trials Unit;   Velindre NHS Trust;   June Hancock Mesothelioma Research Fund;   Velindre Cancer Centre Stepping Stones Appeal Not yet recruiting – verified March 2012

Read More...

A Comparison of Recall Rates Between Conventional 2d Mammography and 2d Plus 3d (Tomosynthesis) Mammography in a Screening Population

Condition :   Breast Cancer Intervention :   Sponsors :   Rose Imaging Specialists, P.A.;   Hologic, Inc. Recruiting – verified March 2012

Read More...